Cancer Survival in Adults in Spain: A Population-Based Study of the Spanish Network of Cancer Registries (REDECAN)

Guevara, Marcela
Molinuevo, Amaia
Salmerón, Diego
Carulla, Marià
Chirlaque, María Dolores
Rodríguez Camblor, Marta
Alemán, Araceli
Vizcaíno Batllés, Ana
Chico, Matilde
Castro, Visitación de
Sánchez, María-José
Ramalle-Gómara, Enrique
Franch, Paula
Galceran, Jaume
Ardanaz, Eva
Compartir
We studied cancer survival and its trends in adult patients in Spain. We included more than 600,000 patients with primary cancer diagnosed during 2002–2013 and followed them up to 2015. The study provides cancer survival estimates up to five years after diagnosis by sex and age for 29 cancer groups. We found survival improvements for most cancer groups from 2002–2007 to 2008–2013, although with differences by age, being greater for patients younger than 75 years than for older patients. The persistent poor prognosis for some cancers emphasizes the need to reinforce actions along the cancer continuum, from primary prevention to early diagnosis, optimal treatment, and supportive care. Further examination of possible sociodemographic inequalities is warranted ​
Aquest document està subjecte a una llicència Creative Commons:Reconeixement (by) Creative Commons by4.0